In vivo Bioequivalence study of peptilock chewable tablet

Not Applicable

Recruiting

• Conditions: In the present study, no diseases will be examined and products will be administered by healthy volunteers..

• Registration Number: IRCT20210519051345N8
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 January 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

General Health (Liver, Heart and Kidney),

Exclusion Criteria

Smoking,
History of cardiovascular disease, liver and kidney disease,
Pregnancy,
Alcohol and drug addiction,
History of drug allergy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Plasma Drug Concentration. Timepoint: 0.5-12 hours in predetermined time intervals after drug administration. Method of measurement: HPLC (High performance liquid chromatography).